Cognizant (CTSH) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
Cognizant Technology Solutions (CTSH) PT Raised to $78 at Needham & Company
August 3, 2017 12:56 PM EDTNeedham & Company raised its price target on Cognizant Technology Solutions (NASDAQ: CTSH) to $78.00 (from $72.00) while maintaining a Buy rating following "solid" Q2 results.
Analyst Mayank Tandon commented, "CTSH posted solid 2Q results, beating consensus on revenue, margins, and earnings. Growth in... More
Cognizant shrugs off healthcare worry, tightens FY revenue view
August 3, 2017 6:17 AM EDTBy Rishika Sadam
(Reuters) - Cognizant Technology Solutions Corp raised the lower end of its 2017 revenue forecast, easing concerns of tighter spending from its healthcare clients amid uncertainty surrounding the U.S. healthcare policy.
The healthcare sector's worry has been taking a toll on IT services providers lately, forcing them to give bleak forecasts.
The Republican quest to scrap Obamacare, a major campaign vow by U.S. President Donald Trump, failed last week, after the Senate failed to dismantle the healthcare law.
Cognizant gets a large chunk of its revenue from financial services and healthcare... More
